Loading IPO Details...
Upcoming IPOs
Healthcare Service Provider · Listed on NSE · 18 Jun 2026 - 22 Jun 2026
Jagat JoshiAvience Biomedicals Limited, founded in June 2024, is a prominent manufacturer, supplier, and exporter of molecular diagnostic products, testing solutions, and laboratory equipment. The firm specializes in molecular biotechnology, genomics, and in vitro diagnostics (IVD). Avience Biomedicals Limited enhanced its product range from IVD rapid test kits to an extensive line of medical devices, including biochemistry, hematology, and serology products.
Its product range includes Rapid Test Kits, Biochemistry Analyzers and Reagents, Molecular Diagnostics, Hematology Analyzers, and Medical Devices. The company’s products are distributed to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide and overseas as well. Along with manufacturing, the firm also serves as a distributor and trader of medical equipment. Moreover, its manufacturing facility is located in Noida, Uttar Pradesh.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 25-Jun-2026 12:00 PM | +₹145 | ₹353 | +69.71% | ₹87,000 |
| 24-Jun-2026 12:00 PM | +₹95 | ₹303 | +45.67% | ₹57,000 |
| 23-Jun-2026 12:00 PM | +₹72 | ₹280 | +34.62% | ₹43,200 |
| 22-Jun-2026 12:00 PM | +₹70 | ₹278 | +33.65% | ₹42,000 |
| 20-Jun-2026 12:00 PM | +₹85 | ₹293 | +40.87% | ₹51,000 |
| 19-Jun-2026 12:00 PM | +₹85 | ₹293 | +40.87% | ₹51,000 |
| 18-Jun-2026 12:00 PM | +₹75 | ₹283 | +36.06% | ₹45,000 |
| 17-Jun-2026 12:00 PM | +₹75 | ₹283 | +36.06% | ₹45,000 |
| 16-Jun-2026 12:00 PM | +₹70 | ₹278 | +33.65% | ₹42,000 |
| 15-Jun-2026 12:00 PM | +₹40 | ₹248 | +19.23% | ₹24,000 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| Anchor | 1.00x | 4,09,800 | 4,09,800 | ₹8.52 Cr |
| QIB (Ex. Anchor) | 196.77x | 2,73,600 | 5,38,37,400 | ₹1,119.82 Cr |
| NII | 597.23x | 2,07,000 | 12,36,27,600 | ₹2,571.45 Cr |
| bNII > ₹10L | 670.18x | 1,38,000 | 9,24,84,600 | ₹1,923.68 Cr |
| sNII < ₹10L | 451.35x | 69,000 | 3,11,43,000 | ₹647.77 Cr |
| Retail | 401.36x | 4,81,200 | 19,31,32,800 | ₹4,017.16 Cr |
| Total | 270.49x | 13,71,600 | 37,10,07,600 | ₹7,716.96 Cr |
| Period Ended | 31 JAN 2026 | 31 MAR 2025 | 31 MAR 2024 |
|---|---|---|---|
| Total Income | 41.94 | 45.97 | 23.00 |
| Profit After Tax | 5.74 | 7.23 | 2.14 |
| EBITDA | 10.34 | 11.41 | 4.08 |
| NET Worth | 24.49 | 22.78 | 6.21 |
| Reserves and Surplus | 24.49 | 18.75 | 2.93 |
| Total Borrowing | 26.73 | 22.16 | 15.13 |
Peer comparison data will be updated soon.
Mr. Dharam Deo Choudhary, Mr. Dharam Deo Choudhary, Mr. Janardan Pal, and Ms. Deepa Choudhary is the company's promoter of Avience Biomedicals.
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 87.89% | 64.59% |
| Others* | 12.11% | 35.41% |
Join the discussion
Please sign in to leave a comment or reply.